ETC-66731-16649 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-07-21
Dose 1 — Pfizer-BioNTech
2022-07-24
Registered in v-safe
2022-07-24
Survey response — days 1–6 daily, dose 1, dependent
MedDRA: Decreased appetite — Feeling: Good

Free text: Loss of appetite

MedDRA releases: 2024-11 · check-in free text available
2022-07-25
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2022-07-26
Survey response — days 1–6 daily, dose 1, dependent
MedDRA: Eye irritation — Feeling: Fair · Fatigue or tiredness

Free text: (b)(6) has complained of her eyes burning

MedDRA releases: 2024-11 · check-in free text available
2022-07-27
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2022-07-28
Health check-in — day 7, dose 1, dependent
Feeling: Good · None

Adult check-in
2022-08-04
Survey response — day 14, dose 1, dependent
MedDRA: Lacrimation increased, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activities

Free text: Congestion, watery eyes, and slight fever.

MedDRA releases: 2024-11 · check-in free text available
2022-08-11
Dose 2 — Pfizer-BioNTech
2022-08-18
Health check-in — day 7, dose 2, dependent
Feeling: Good · None

Adult check-in
2022-08-25
Health check-in — day 14, dose 2, dependent
Feeling: Good

Adult check-in
2022-09-01
Health check-in — day 21, dose 2, dependent
Feeling: Good

Adult check-in
2022-09-08
Health check-in — day 28, dose 2, dependent
Feeling: Good

Adult check-in
2022-09-17
Health check-in — day 35, dose 2, dependent
Feeling: Good

Adult check-in
2022-09-22
Survey response — day 42, dose 2, dependent
MedDRA: Feeling hot — Feeling: Fair

Free text: Her body temperature has been running warmer than is usual. Not feverish and she doesn't voice additional symptoms, but she is warmer than what is normal for her.

MedDRA releases: 2024-11 · check-in free text available
2022-11-12
Health check-in — 3 months, dose 2, dependent
Feeling: Good

Adult check-in
2023-02-09
Health check-in — 6 months, dose 2, dependent
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-07-21	Pfizer-BioNTech	No
2	2022-08-11	Pfizer-BioNTech	No

Free text

Release 12 — days 1–6 daily, dose 1, dependent

2022-07-24

Systemic reaction (other): Loss of appetite

2022-07-26

Systemic reaction (other): (b)(6) has complained of her eyes burning

redacted (b)(6)

Release 12 — day 14, dose 1, dependent

2022-08-04

Symptoms: Congestion, watery eyes, and slight fever.

Release 12 — day 42, dose 2, dependent

2022-09-22

Symptoms: Her body temperature has been running warmer than is usual. Not feverish and she doesn't voice additional symptoms, but she is warmer than what is normal for her.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Feeling hot	·	·	✓
SD	Lacrimation increased	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SRO	Decreased appetite	·	·	✓
SRO	Eye irritation	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release